Sinha R, Bruinstroop E, Yen P
Nat Rev Gastroenterol Hepatol. 2024; 22(1):9-22.
PMID: 39420154
PMC: 7616774.
DOI: 10.1038/s41575-024-00991-4.
Salman A, Aon M, Hussein A, Salman M, Tourky M, Mahmoud A
Int J Gen Med. 2021; 14:5711-5718.
PMID: 34557025
PMC: 8455075.
DOI: 10.2147/IJGM.S326315.
Gauthier B, Sola-Garcia A, Caliz-Molina M, Lorenzo P, Cobo-Vuilleumier N, Capilla-Gonzalez V
Aging Cell. 2020; 19(11):e13260.
PMID: 33048427
PMC: 7681062.
DOI: 10.1111/acel.13260.
Huang P, Wang C, Yeh C, Lin K
Int J Mol Sci. 2019; 20(20).
PMID: 31640265
PMC: 6834183.
DOI: 10.3390/ijms20205220.
Liu Y, Yeh C, Lin K
Int J Mol Sci. 2019; 20(20).
PMID: 31600974
PMC: 6834155.
DOI: 10.3390/ijms20204986.
The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer.
Gionfra F, De Vito P, Pallottini V, Lin H, Davis P, Pedersen J
Front Endocrinol (Lausanne). 2019; 10:532.
PMID: 31543862
PMC: 6730500.
DOI: 10.3389/fendo.2019.00532.
Analysis of Thyroid Tumorigenesis in Xenograft Mouse Model.
Zhu X, Cheng S
Methods Mol Biol. 2018; 1801:207-223.
PMID: 29892827
PMC: 7971365.
DOI: 10.1007/978-1-4939-7902-8_17.
Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
Chi H, Chen S, Lin S, Tsai C, Chuang W, Lin Y
Oncogene. 2017; 36(37):5274-5284.
PMID: 28504722
DOI: 10.1038/onc.2017.136.
Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy.
Chi H, Chen S, Tsai C, Chuang W, Huang Y, Tsai M
Autophagy. 2016; 12(12):2271-2285.
PMID: 27653365
PMC: 5173272.
DOI: 10.1080/15548627.2016.1230583.
The role of thyroid hormone signaling in the prevention of digestive system cancers.
Brown A, Simmen R, Simmen F
Int J Mol Sci. 2013; 14(8):16240-57.
PMID: 23924944
PMC: 3759909.
DOI: 10.3390/ijms140816240.
Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.
Chi H, Chen C, Tsai M, Tsai C, Lin K
Biomed Res Int. 2013; 2013:601361.
PMID: 23878812
PMC: 3708403.
DOI: 10.1155/2013/601361.
Thyroid hormone actions in liver cancer.
Wu S, Cheng W, Lin C, Lin K
Cell Mol Life Sci. 2012; 70(11):1915-36.
PMID: 22955376
PMC: 11113324.
DOI: 10.1007/s00018-012-1146-7.
Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL.
Chi H, Chen S, Liao C, Liao C, Tsai M, Lin Y
Cell Death Differ. 2012; 19(11):1802-14.
PMID: 22576662
PMC: 3469053.
DOI: 10.1038/cdd.2012.58.
Thyroid hormone receptors and cancer.
Kim W, Cheng S
Biochim Biophys Acta. 2012; 1830(7):3928-36.
PMID: 22507269
PMC: 3406244.
DOI: 10.1016/j.bbagen.2012.04.002.
Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.
Rosen M, Privalsky M
J Thyroid Res. 2011; 2011:361304.
PMID: 21760978
PMC: 3134260.
DOI: 10.4061/2011/361304.
Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
Guigon C, Kim D, Willingham M, Cheng S
Oncogene. 2011; 30(30):3381-90.
PMID: 21399657
PMC: 3457781.
DOI: 10.1038/onc.2011.50.
The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
Ventura-Holman T, Mamoon A, Subauste M, Subauste J
Mol Biol Rep. 2010; 38(2):1137-44.
PMID: 20571909
DOI: 10.1007/s11033-010-0211-2.
Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.
Chan I, Privalsky M
Oncogene. 2009; 28(47):4162-74.
PMID: 19749797
PMC: 2787677.
DOI: 10.1038/onc.2009.265.
Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity.
Rosen M, Privalsky M
Mol Endocrinol. 2009; 23(8):1183-92.
PMID: 19407221
PMC: 2718749.
DOI: 10.1210/me.2009-0126.
Novel oncogenic actions of TRbeta mutants in tumorigenesis.
Guigon C, Cheng S
IUBMB Life. 2009; 61(5):528-36.
PMID: 19391168
PMC: 2716728.
DOI: 10.1002/iub.180.